Victoria Vezina - 06 Feb 2024 Form 4 Insider Report for RAPID MICRO BIOSYSTEMS, INC. (RPID)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Feb 2024, 17:04:33 UTC
Prior SEC filing
13 Mar 2023
Next SEC filing
14 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean M. Wirtjes, Attorney-in-Fact for Victoria Vezina

Key filing fact

Victoria Vezina filed Form 4 for RAPID MICRO BIOSYSTEMS, INC. (RPID) on 08 Feb 2024.

Key facts

  • This page summarizes Victoria Vezina's Form 4 filing for RAPID MICRO BIOSYSTEMS, INC. (RPID).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 Feb 2024, 17:04.

Change

  • Previous filing in this sequence was filed on 13 Mar 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RPID transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+28,000
Change %
+30%
Price
$0.000000
Shares after
120,770
Date
06 Feb 2024
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RPID transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+56,000
Change %
Price
$0.000000
Shares after
56,000
Date
06 Feb 2024
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
56,000
Exercise price
$0.9420
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Grant of restricted stock units ("RSUs") that vest in three annual installments with 33.4% vesting on the first anniversary of February 6, 2024 (the "grant date") and 33.3% vesting on each of the second and third anniversaries of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Footnote F2

Includes 6,739 shares acquired under the Rapid Micro Biosystems, Inc. employee stock purchase plan on March 14, 2023.

Footnote F3

The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 6, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .